Meeting
2022 ASCO Gastrointestinal Cancers Symposium
KRAS mutation methylation clonality in early-stage pancreatic cancer.
Authors
Jeanne Kowalski
Livestrong Cancer Institutes, The University of Texas at Austin Dell Medical School, Austin, TX
Jeanne Kowalski , Qi Xu , Hsueh Ping Chao , Heta Gandhi , Kyaw Lwin Aung , William H. Matsui
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.614
Abstract #
614
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Shared DNA-based copy number with divided methylation changes differentiate and clinically associate early stage pancreatic cancer tumors.
First Author: Eva Chao
Poster
2012 Gastrointestinal Cancers Symposium
Association of KRAS G12D mutation with outcome in patients with pancreatic cancer after surgery.
First Author: Yo Mikayama
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox
Poster
2023 ASCO Annual Meeting
Co-mutational status and PD-L1 expression in KRAS mutant non-small cell lung cancer (NSCLC): Role in treatment selection and association with clinical outcomes.
First Author: Hina Khan